NICE CKS candida—female genital
This summary has been developed for use by community pharmacists under our Guidelines for Pharmacy title and therefore only covers the information relevant to this setting. Please refer to the full guideline for the complete set of recommendations.
NICE LARC guideline
This guideline covers important points to raise with women that may benefit from long-acting reversible contraception
NICE recommendations for women with pelvic organ prolapse
Summary includes recommendations on non-surgical management of prolapse, and assessment and management of complications associated with mesh surgery.
Urinary incontinence and pelvic organ prolapse in women: management
Summary of NICE guidance covers history taking, assessing urinary incontinence, investigations, non-surgical management, and indicators for referral.
SIGN FASD guideline
Failure to recognise prenatal alcohol exposure as a possible cause of behavioural difficulties may contribute to adverse outcomes for the child.
Educational resources
Hormone replacement therapy (HRT) shortage: switching to Femoston® (estradiol/dydrogesterone) from an alternative combination oral or transdermal HRT
Information for healthcare professionals only.
The importance of the progestogenic component of hormone replacement therapy in women with a uterus
Information intended for healthcare professionals only.